Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life

被引:4
|
作者
Chen, Vivi W. W. [1 ,2 ]
Portuondo, Jorge I. [2 ]
Cooper, Zara [3 ,4 ]
Massarweh, Nader N. [5 ,6 ,7 ]
机构
[1] Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA
[2] Baylor Coll Med, Michael E DeBakey Dept Surg, 2002 Holcombe Blvd,OCL 112, Houston, TX 77030 USA
[3] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA
[4] Brigham & Womens Hosp, Dept Surg, Boston, MA USA
[5] Atlanta VA Hlth Care Syst, Surg & Perioperat Care, Decatur, GA USA
[6] Emory Univ, Dept Surg, Div Surg Oncol, Sch Med, Atlanta, GA USA
[7] Morehouse Sch Med, Dept Surg, Atlanta, GA USA
关键词
end of life; gastrointestinal cancer; hospital variation; palliative; CLINICAL-PRACTICE GUIDELINES; MEDICARE BENEFICIARIES; GASTRIC-CANCER; OLDER-ADULTS; CARE; OUTCOMES; TRENDS; ESOPHAGEAL; QUALITY; COLON;
D O I
10.1002/jso.27177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundPatients with advanced gastrointestinal (GI) cancer often undergo noncurative interventions with palliative intent to relieve high symptom burden near end of life. Hospital-level variation in intervention utilization remains unclear. MethodsNational cohort study of 142 304 patients with stage III or IV GI cancer within the National Cancer Database (2004-2014) who died within 1-year of diagnosis. Hospitals were stratified by palliative intervention utilization (surgery, chemotherapy, radiation, pain management). Multivariable, multinomial regression evaluated the association between patient/hospital factors and palliative intervention utilization. ResultsAcross 1322 hospitals, median hospital palliative intervention utilization was 12.0% [interquartile range: 0.0%-26.1%]. Utilization increased over time in all but lowest utilizing hospitals. Relative to lowest utilizing hospitals, factors associated with a lower likelihood of care at highest utilizing hospitals included: race (White [ref]; Black-Relative Risk Ratio [RRR] 0.81, 95% confidence interval [0.77-0.85]) and lower income (RRR 0.81 [0.78-0.84]). Factors associated with a higher likelihood included: lower education level (RRR 1.62 [1.55-1.69]) and hospital type (community program [ref]; comprehensive community-RRR 1.33 [1.26-1.41]; academic-RRR 1.88 [1.77-1.99]; integrated network-RRR 1.79 [1.66-1.93]). ConclusionHospital variation in palliative intervention use is substantial and potentially associated with sociodemographic and hospital characteristics. Future work can examine how differences in hospital care processes translate to quantity/quality of life for cancer patients.
引用
收藏
页码:741 / 751
页数:11
相关论文
共 50 条
  • [21] Palliative care training can help patients with advanced cancer at the end of life
    Nierengarten, Mary Beth
    [J]. CANCER, 2023, 129 (16)
  • [22] End-of-life outcomes of patients with advanced cancer enrolled in palliative care
    Lynch, Andrew
    Lyon, Liisa
    Ramalingam, Nirmala D.
    Whitehead, Hannah
    Chang, Mina
    Liu, Raymond
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Palliative Medicine Referral Patterns and End-of-Life Interventions Among Patients with Advanced or Metastatic Gynecologic Cancer in a University Cancer Center
    Sanchez, Julia
    Tabuyo, Angel
    Morales, Angelica Torres
    Pitteloud, Marie Joelle
    Kshetry, Alisha
    Schlumbrecht, Matthew
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2022, 63 (05) : 897 - 897
  • [24] PALLIATIVE CARE AND RESOURCE UTILIZATION AT THE END OF LIFE IN ADVANCED LIVER DISEASE
    Patel, Arpan A.
    Walling, Anne M.
    Saab, Sammy
    Wenger, Neil
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S321 - S321
  • [25] Palliative Chemotherapy Near the End of Life in Oncology Patients
    Zhang, Zhe
    Chen, Meng-Lei
    Gu, Xiao-Li
    Liu, Ming-Hui
    Zhao, Wei-Wei
    Cheng, Wen-Wu
    [J]. AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2018, 35 (09): : 1215 - 1220
  • [26] Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life
    Nakayama, Hirokazu
    Echizen, Hirotoshi
    Ogawa, Ryuichi
    Orii, Takao
    Kato, Toshiaki
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (01) : 77 - 82
  • [27] Administration of chemotherapy to advanced lung cancer patients near the end of life
    Watanabe, Kageaki
    Nagamata, Makoto
    Yomota, Makiko
    Zenke, Yoshitaka
    Okuma, Yusuke
    Hosomi, Yukio
    Okamura, Tatsuru
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 83 - 83
  • [28] Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life
    Hirokazu Nakayama
    Hirotoshi Echizen
    Ryuichi Ogawa
    Takao Orii
    Toshiaki Kato
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 77 - 82
  • [29] Palliative Tracheostomy at the End of Life: Utilization in a Patient with Metastatic Cancer
    Risaliti, Carleen
    Gustin, Jillian
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (10) : 1052 - 1053
  • [30] Palliative interventions and prognosis in patients with advanced esophageal cancer
    Amdal, C. D.
    Jacobsen, A-B
    Tausjo, J. E.
    Wiig, J. N.
    Warloe, T.
    Sandstad, B.
    Bjordal, K.
    [J]. DISEASES OF THE ESOPHAGUS, 2011, 24 (07) : 502 - 509